procarbazine has been researched along with Focal Neurologic Deficits in 2 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, HD | 1 |
| Walker, MD | 1 |
| Wiernik, PH | 1 |
| Cambier, J | 1 |
| Masson, M | 1 |
| Lhuillier, M | 1 |
1 review available for procarbazine and Focal Neurologic Deficits
| Article | Year |
|---|---|
Neurotoxicity of commonly used antineoplastic agents (second of two parts).
Topics: Achilles Tendon; Animals; Antineoplastic Agents; Autonomic Nervous System; Central Nervous System Di | 1974 |
1 other study available for procarbazine and Focal Neurologic Deficits
| Article | Year |
|---|---|
[Amnesiant encephalitis and Hodgkin's disease].
Topics: Adult; Amnesia; Electroencephalography; Encephalitis; Hodgkin Disease; Humans; Immunotherapy; Male; | 1973 |